Week Ending October 4th, 2024:
Biotech: 2 Transactions (1 Follow-On and 1 RM Closing) totaling just under $500 Million
Med Tech: 1 Transaction (1 RD) totaling $30 Million
2024 YTD:
218 Biotech transactions totaling just under $39 Billion v. 2023 YTD: 137 Biotech transactions totaling just over $20 Billion
11 Med Tech transactions totaling just over $1 Billion v. 2023 YTD: 15 Med Tech transactions totaling just over $1 Billion
Private Transactions:
Biotech: 207 US Transactions / 83 European Transactions
Med Tech: 137 US Transactions / 47 European Transactions
September Deal:
Organon acquired Dermavant for $175M
August Deals:
Crown Laboratories acquired Revance for $924M or $6.66/share
Pharmacosmos acquired G1 Therapeutics for $405M or $7.15/share
Otsuka Pharmaceutical acquired Jnana Therapeutics for $800M
Comments